Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05945563 · ClinicalTrials.gov registry record
Clopidogrel Hyper-Responsiveness: Incidence and Associated Outcomes in Patients With Cerebral Aneurysms
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 208
- Enrollment target
NCT05945563 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 208 participants.
The verdict
NCT05945563 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 208 participants
- Enrollment target
Study Summary
This registry study will investigate the incidence of and outcomes associated with clopidogrel hyper-responsive patients treated at Methodist Dallas Medical Center, beginning in January 2018, who suffered cerebral aneurysms.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2023-01-17 |
| Est. Completion | 2025-07-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05945563
The ClinicalTrials.gov registry entry for NCT05945563 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05945563 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05945563 about?
NCT05945563 is a clinical study titled "Clopidogrel Hyper-Responsiveness: Incidence and Associated Outcomes in Patients With Cerebral Aneurysms". This registry study will investigate the incidence of and outcomes associated with clopidogrel hyper-responsive patients treated at Methodist Dallas Medical Center, beginning in January 2018, who suffered cerebral aneurysms.
What is the current status of trial NCT05945563?
This trial is currently completed. The enrollment target is 208 participants. The study started on 2023-01-17. Estimated completion is 2025-07-18.
Who is sponsoring clinical trial NCT05945563?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.